Clinical Trial Update: Efficacy of Pregnenolone in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pregnenolone for efficacy in schizophrenia and schizoaffective disorder has completed. The study was sponsored by Weill Medi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED